High-dose targeted radiation with (131)I-apamistamab prior to HCT demonstrated a dose-response for durable complete remission in patients with R/R AML Meeting Abstract

  

Authors:	Litzow, M. R.; Chen, G.; Gyurkocza, B.; Nath, R.; Seropian, S.; Choe, H.; Abboud, C. N.; Koshy, N.; Tomlinson, B. K.; Abhyankar, S.; Foran, J. M.; Abedin, S.; Al-Kadhimi, Z.; Kebriaei, P.; Sabloff, M.; Orozco, J. J.; Jamieson, K. J.; Magalhaes-Silverman, M.; Van Besien, K.; Schuster, M. W.; Law, A. D.; Mayer, S. A.; Lazarus, H. M.; Leung, E.; Chen, M. K.; Natwa, M.; Spross, J.; Li, K. L.; Nagl, N.; Haeuber, E.; Vusirikala, M.; Nahar, A.; Sandmaier, B. M.; Pagel, J.; Giralt, S. A.; Desai, A.; Wahl, R. L.; Pandit-Taskar, N.; Brodin, P.; Stiff, P. J.
Abstract Title:	High-dose targeted radiation with (131)I-apamistamab prior to HCT demonstrated a dose-response for durable complete remission in patients with R/R AML
Meeting Title:	65th Annual Meeting of the American Society of Hematology (ASH)
Journal Title:	Blood
Volume:	142
Issue:	Suppl. 1
Meeting Dates:	2023 Dec 9-12
Meeting Location:	San Deigo, CA
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2023-11-02
Start Page:	3529
Language:	English
ACCESSION:	WOS:001159740304140
DOI:	10.1182/blood-2023-189040
PROVIDER:	wos
Notes:	Meeting Abstract -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/215442